Class Action Lawsuit Filed Against Regencell Bioscience Holdings Limited

A class action lawsuit has been filed against Regencell Bioscience (NASDAQ: RGC) and certain officers for alleged violations of federal securities laws. The case seeks to recover damages from investors who purchased the company's securities between October 28, 2024, and October 31, 2025.

By Pomerantz LLP · PR Newswire · June 4, 2026, 14:00 UTC

Tickers: $RGC

Topics: investors lawsuits securities-fraud

Read the full article at PR Newswire

More Politics news

Pomerantz Law Firm Investigates Greenland Energy (GLND) Following Short Seller Report PR Newswire · November 12, 2026, 16:15 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at Foghorn Therapeutics (FHTX) PR Newswire · November 12, 2026, 16:00 UTC
Pomerantz Law Firm Investigates VinFast Auto Ltd. Following Significant Operating Losses PR Newswire · November 12, 2026, 15:55 UTC
Class Action Lawsuit Filed Against Skechers U.S.A., Inc. Regarding Take-Private Acquisition PR Newswire · November 12, 2026, 15:00 UTC
Class Action Lawsuit Filed Against Compass, Inc. Regarding Merger Disclosures PR Newswire · November 12, 2026, 15:00 UTC
Scott Colom Defeats Incumbent Cindy Hyde-Smith in Mississippi Senate Election CNBC · November 11, 2026, 23:03 UTC
Advocacy Groups Prepare to Pressure Politicians Over Data Center Restrictions Following Midterm Elections The Verge · November 11, 2026, 21:56 UTC
Alleged Security Concerns Involving Nvidia CEO Jensen Huang Prompt US-Taiwan Official Concern The Verge · November 11, 2026, 19:22 UTC
Scott Colom Maintains Narrow Lead Over Cindy Hyde-Smith in Mississippi Senate Race CNBC · November 10, 2026, 21:55 UTC
Jim Jordan Elected House Republican Minority Leader CNBC · November 10, 2026, 19:55 UTC